Author: Guo-Qing Qian; Nai-Bin Yang; Feng Ding; Ada Hoi Yan Ma; Zong-Yi Wang; Yue-Fei Shen; Chun-Wei Shi; Xiang Lian; Jin-Guo Chu; Lei Chen; Zhi-Yu Wang; Da-Wei Ren; Guo-Xiang Li; Xue-Qin Chen; Hua-Jiang Shen; Xiao-Min Chen
Title: Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series Document date: 2020_2_25
ID: jxtch47t_34
Snippet: Currently, no anti-viral agents have been proven to be effective treatment for COVID-19. It is reported that combination of Lopinavir and Ritonavir had been applied to SARS-CoV-2 patients with substantial clinical benefit. 22 As an emerging virus, all the patients received anti-viral agents in Ningbo cohort, including Kaletra (Lopinavir/Ritonavir) and Umifenovir, 9 cases received methylprednisolone to treat high fever, SpO2 ≤93% and hypoxiemia......
Document: Currently, no anti-viral agents have been proven to be effective treatment for COVID-19. It is reported that combination of Lopinavir and Ritonavir had been applied to SARS-CoV-2 patients with substantial clinical benefit. 22 As an emerging virus, all the patients received anti-viral agents in Ningbo cohort, including Kaletra (Lopinavir/Ritonavir) and Umifenovir, 9 cases received methylprednisolone to treat high fever, SpO2 ≤93% and hypoxiemia. The dose of methylprednisolone depends on disease severity between 1mg/kg to 2mg/kg. However, the outcome is still unclear.
Search related documents:
Co phrase search for related documents- 1mg kg and high fever: 1
- 1mg kg and methylprednisolone dose: 1
- 1mg kg and methylprednisolone receive: 1
- 1mg kg and SARS patient: 1, 2
- anti viral agent and disease severity: 1
- anti viral agent and effective treatment: 1, 2, 3
- clinical benefit and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- clinical benefit and effective treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- clinical benefit and emerge virus: 1
- clinical benefit and Ritonavir Lopinavir combination: 1
- clinical benefit and SARS patient: 1, 2, 3, 4, 5, 6
- clinical benefit and substantial clinical benefit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- disease severity and effective treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- disease severity and high fever: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- disease severity and methylprednisolone dose: 1, 2
- disease severity and methylprednisolone receive: 1
- disease severity and Ritonavir Lopinavir combination: 1, 2, 3, 4, 5, 6, 7, 8
- disease severity and SARS patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61
- effective treatment and high fever: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date